- Filed
- May 16, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 13, 2025 | 20.64M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $3.8M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $3.97M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $4.83M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $9.44M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $51.66M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $64.68M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $55.46M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $68.66M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $51.23M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $65.96M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $77.49M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $93.62M |
| Total Assets | Q1 2025 · Sep 30, 2024 | $77.49M |
| Total Assets restated | Q1 2025 · Dec 31, 2023 | $93.62M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 13.9M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$132K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $28.75M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $34.4M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.45 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.45 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $10.37M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $4.84M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$6.28M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$3.95M |
| Revenue | Q1 2025 · Mar 31, 2024 | $65.98M |